---
figid: PMC7940178__fimmu-12-606384-g0001
figlink: pmc/articles/PMC7940178/figure/F1/
number: F1
caption: HCA2 triggers different downstream signaling pathway in different cell types.
  (A) In adipocytes, activation of HCA2 triggers a Gαi-mediated inhibition of adenylate
  cyclase activity, which leads to lower intracellular cAMP levels, reduced protein
  kinase A (PKA) activity, and further reduces the activity of hormone sensitive lipase
  (HSL), an important lipolytic enzyme. This inhibition of lipolysis results in a
  decreased release of free fatty acids into the circulation. (B) In hepatocytes,
  activation of HCA2 mediates the protein kinase C (PKC)-extracellular signal-regulated
  kinase (ERK) signaling pathway, leading to phosphorylation of AMP-activated protein
  kinase (AMPK) and inhibition of acetyl CoA carboxylase (ACC). This results in an
  inhibition of hepatic de novo lipogenesis and a remarkable decrease of lipid accumulation
  in liver. (C) In colonocytes, ligand binding to HCA2 suppresses NF-κB activation
  and activates NLRP3 inflammasome, which recruits caspase-1 and promotes the maturation
  of IL-18 for secretion. (D) In retinal pigment epithelium, HCA2 exerts either an
  anti-inflammatory response through the Gαi/cAMP/NF-κB pathway, or apoptosis through
  the Gβγ/Ca2+/NOX4/ROS/JNK pathway. (E) Within Langerhans cells, HCA2-mediated Gαi
  activation primarily results in the Gβγ-complex released from activated Gαi, thereby
  increasing intracellular calcium concentration by mobilizing Ca2+ release from the
  endoplasmic reticulum and ultimately driving the formation of PGD2 and PGE2, which
  are released to the dermal layer and cause cutaneous flushing reaction. (F) In macrophages,
  activation of HCA2 involves inhibition of NF-κB, thereby exerting an anti-inflammatory
  effec. HCA2 activation in macrophages also represses F-actin and blocks Gβγ signaling
  to inhibit chemokine-induced migration of macrophages. HCA2 also shows anti-inflammatory
  effects in Parkinson's disease models by inhibiting the phosphorylation of the NF-κB
  p65 signaling pathway in microglia. HCA2 suppresses LPS-induced NF-κB activation
  in human monocytes, resulting in decreased transcription of IL-6, TNFα, and MCP-1.
  In DCs, HCA2 activation decreases IL-6 level and increases IL-10 level, also upregulates
  expression of RALDH1, which synthesizes RA from retinol. RA and IL-10 promote Treg
  cell proliferation. In neutrophils, niacin-mediated HCA2 activation inhibits PKA
  activity and subsequently increase BAD levels, which drives apoptosis of neutrophils.
pmcid: PMC7940178
papertitle: Role of HCA2 in Regulating Intestinal Homeostasis and Suppressing Colon
  Carcinogenesis.
reftext: Zhuoyue Li, et al. Front Immunol. 2021;12:606384.
pmc_ranked_result_index: '32647'
pathway_score: 0.9051174
filename: fimmu-12-606384-g0001.jpg
figtitle: HCA2 triggers different downstream signaling pathway in different cell types
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7940178__fimmu-12-606384-g0001.html
  '@type': Dataset
  description: HCA2 triggers different downstream signaling pathway in different cell
    types. (A) In adipocytes, activation of HCA2 triggers a Gαi-mediated inhibition
    of adenylate cyclase activity, which leads to lower intracellular cAMP levels,
    reduced protein kinase A (PKA) activity, and further reduces the activity of hormone
    sensitive lipase (HSL), an important lipolytic enzyme. This inhibition of lipolysis
    results in a decreased release of free fatty acids into the circulation. (B) In
    hepatocytes, activation of HCA2 mediates the protein kinase C (PKC)-extracellular
    signal-regulated kinase (ERK) signaling pathway, leading to phosphorylation of
    AMP-activated protein kinase (AMPK) and inhibition of acetyl CoA carboxylase (ACC).
    This results in an inhibition of hepatic de novo lipogenesis and a remarkable
    decrease of lipid accumulation in liver. (C) In colonocytes, ligand binding to
    HCA2 suppresses NF-κB activation and activates NLRP3 inflammasome, which recruits
    caspase-1 and promotes the maturation of IL-18 for secretion. (D) In retinal pigment
    epithelium, HCA2 exerts either an anti-inflammatory response through the Gαi/cAMP/NF-κB
    pathway, or apoptosis through the Gβγ/Ca2+/NOX4/ROS/JNK pathway. (E) Within Langerhans
    cells, HCA2-mediated Gαi activation primarily results in the Gβγ-complex released
    from activated Gαi, thereby increasing intracellular calcium concentration by
    mobilizing Ca2+ release from the endoplasmic reticulum and ultimately driving
    the formation of PGD2 and PGE2, which are released to the dermal layer and cause
    cutaneous flushing reaction. (F) In macrophages, activation of HCA2 involves inhibition
    of NF-κB, thereby exerting an anti-inflammatory effec. HCA2 activation in macrophages
    also represses F-actin and blocks Gβγ signaling to inhibit chemokine-induced migration
    of macrophages. HCA2 also shows anti-inflammatory effects in Parkinson's disease
    models by inhibiting the phosphorylation of the NF-κB p65 signaling pathway in
    microglia. HCA2 suppresses LPS-induced NF-κB activation in human monocytes, resulting
    in decreased transcription of IL-6, TNFα, and MCP-1. In DCs, HCA2 activation decreases
    IL-6 level and increases IL-10 level, also upregulates expression of RALDH1, which
    synthesizes RA from retinol. RA and IL-10 promote Treg cell proliferation. In
    neutrophils, niacin-mediated HCA2 activation inhibits PKA activity and subsequently
    increase BAD levels, which drives apoptosis of neutrophils.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - MAPK1
  - PRKCA
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCQ
  - PRKCB
  - PRKCD
  - PRKCI
  - PRKCZ
  - PRKD3
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - NLRP3
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - CASP1
  - CASP2
  - CASP8
  - CASP9
  - CASP14
  - CASP12
  - CASP3
  - CASP4
  - CASP5
  - CASP6
  - CASP7
  - CASP10
  - ACACB
  - ACACA
  - IL18
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - LIPE
  - TG
  - BAD
  - PLCB3
  - PLCB4
  - PLCG1
  - PLCB1
  - PLCE1
  - PLCD4
  - PLCD3
  - PLCB2
  - PLCD1
  - PLCG2
  - PLCZ1
  - PGD
  - NEB
  - IL6
  - TNF
  - Retinol
  - ATP
  - HCA
  - Adenylate
  - Adenylate Ca
  - tumor
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: (NF-KB.
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: (NF-KB.
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: (NF-KB.
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: (NF-KB.
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: (NF-KB.
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: HSL
  symbol: HSL
  source: hgnc_alias_symbol
  hgnc_symbol: LIPE
  entrez: '3991'
- word: TG
  symbol: TG
  source: hgnc_symbol
  hgnc_symbol: TG
  entrez: '7038'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: 'PGD:'
  symbol: PGD
  source: hgnc_symbol
  hgnc_symbol: PGD
  entrez: '5226'
- word: NE-B
  symbol: NEB
  source: hgnc_symbol
  hgnc_symbol: NEB
  entrez: '4703'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: TNFa
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
chemicals:
- word: Retinol
  source: MESH
  identifier: D014801
- word: ATP
  source: MESH
  identifier: D000255
- word: HCA
  source: MESH
  identifier: C452561
- word: Adenylate
  source: MESH
  identifier: C017987
- word: Adenylate Ca
  source: MESH
  identifier: C017987
diseases:
- word: tumor
  source: MESH
  identifier: D009369
figid_alias: PMC7940178__F1
redirect_from: /figures/PMC7940178__F1
figtype: Figure
---
